Filing Details

Accession Number:
0001209191-19-004779
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-01-22 17:09:18
Reporting Period:
2019-01-18
Accepted Time:
2019-01-22 17:09:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1626199 Alpine Immune Sciences Inc. ALPN () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1341382 N James Topper C/O Alpine Immune Sciences, Inc.
201 Elliott Avenue West, Suite 230
Seattle WA 98119
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-01-18 372,439 $5.37 2,571,450 No 4 P Indirect By Frazier Life Sciences VIII, L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Frazier Life Sciences VIII, L.P.
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrant (Right to Buy) Acquisiton 2019-01-18 145,251 $0.00 145,251 $12.74
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
145,251 2019-01-18 2024-01-18 No 4 P Indirect
Footnotes
  1. The reportable securities are held directly by Frazier Life Sciences VIII, L.P. ("FLS LP"). FHM Life Sciences VIII, L.P. ("FHM LP") is the general partner of FLS LP. FHM Life Sciences VIII, L.L.C. ("FHM LLC") is the general partner of FHM LP. James Topper and Patrick Heron are the sole managing members of FHM LLC. Mr. Topper disclaims beneficial ownership of the securities held by FLS LP except, to the extent of his pecuniary interest therein, if any.